Enwei Pharmaceutical Co. Ltd. A301331
▲ PositiveCapitalrelevance
Controlling shareholder's shares unfrozen, reducing cumulative frozen shares to zero, removing a financial overhang.

Enwei Pharmaceutical's controlling shareholder, Chengdu Enwei Investment Group, has had 138,000 shares unfrozen, representing 0.53% of its holdings and 0.13% of the company's total share capital. As a result, the cumulative number of frozen shares held by the controlling shareholder and its concert parties has been reduced to zero. In the first quarter of 2026, the company achieved revenue of 175 million yuan and net profit attributable to the parent company of 12.5 million yuan.
Enwei Pharmaceutical Co. Ltd. AControlling shareholder's shares unfrozen, reducing cumulative frozen shares to zero, removing a financial overhang.